Mach7 TechnologiesASX:M7T -3.39%35 Days Payable is 274.70 as of Dec. 2025, which is 39% above its 10-year median of 197.92. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.83 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Mach7 Technologies ranks better than 90.59% on this metric.
The historical rank and industry rank for Mach7 Technologies's Days Payable or its related term are showing as below:
ASX:M7T'
s Days Payable Range Over the Past 10 Years
Min: 174.55 Med: 197.92 Max: 359.6
Current: 344.54
During the past 13 years, Mach7 Technologies's highest Days Payable was 359.60. The lowest was 174.55. And the median was 197.92.
ASX:M7T's Days Payable is ranked better than 90.59% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs ASX:M7T: 344.54
Mach7 Technologies's Days Payable
declined
from Dec. 2024 (294.04) to Dec. 2025 (274.70).
It may suggest that Mach7 Technologiesaccelerated paying its suppliers.
Mach7 Technologies Days Payable Related Terms
Mach7 Technologies Days Payable Historical Data
* Premium members only.
The historical data trend for Mach7 Technologies's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:M7T vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Mach7 Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Mach7 Technologies's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mach7 Technologies (ASX:M7T) has a Days Payable of 274.70 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mach7 Technologies and its competitors. This is 39% above median its historical median of 197.92. Over the past decade, Mach7 Technologies' Days Payable has ranged from 174.55 to 359.60. According to the industry distribution chart, Mach7 Technologies ranks #57 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 9.4%.
Is Mach7 Technologies' Days Payable too high?
Mach7 Technologies' current Days Payable of 274.70 is 39% above median its 10-year median of 197.92. Over the past 10 years, this metric has ranged from a low of 174.55 to a high of 359.60. The Healthcare Providers & Services industry median Days Payable is 58.21. Mach7 Technologies' value of 274.70 is 372% above this industry median. Based on the distribution chart, Mach7 Technologies ranks #57 out of 606 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mach7 Technologies ranks #57 out of 606 companies for Days Payable. This places Mach7 Technologies in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 58.21. Mach7 Technologies' value of 274.70 is 372% above this benchmark. Historically, Mach7 Technologies' own Days Payable has ranged from 174.55 to 359.60 over the past decade. While the company's 10-year median is 197.92 vs. the industry median of 58.21, Mach7 Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mach7 Technologies's current Days Payable of 274.70 is 372% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Mach7 Technologies and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mach7 Technologies's current Days Payable is 274.70, which is 39% above median its own 10-year median of 197.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.83, compared to a current price of A$0.29 — trading 65.7% below its estimated fair value. The current Days Payable is 274.70, which is 39% above median its 10-year median of 197.92 and 372% above the Healthcare Providers & Services industry median of 58.21. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current Days Payable is 274.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?
Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued.
The current stock price of A$0.29 is trading 65.7% below its estimated GF Value™ of A$0.83.
GuruFocus considers Mach7 Technologies to be Possible Value Trap.
Key valuation signals for ASX:M7T:
Days Payable: 274.70 (39% above median its 10-year median of 197.92)
GF Value™: A$0.83 vs. price of A$0.29 (65.7% below fair value)
Industry Position: 372% above the Healthcare Providers & Services median (#57 of 606)
No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score
Get the complete analysis for ASX:M7T
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:M7T has been successfully added to your 
